U.S. markets closed

Intec Pharma Ltd (NTEC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.4400-0.0200 (-0.58%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/13/2021
Current
12/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
18.15M13.62M19.87M19.62M10.44M
Enterprise Value 3
4.41M-2.44M7.14M9.90M1.72M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
1.250.821.231.380.90
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 7
-0.350.75-2.14-3.81-0.50

Trading Information

Stock Price History

Beta (5Y Monthly) 1.14
52-Week Change 3-33.59%
S&P500 52-Week Change 341.30%
52 Week High 315.8200
52 Week Low 32.2000
50-Day Moving Average 34.0621
200-Day Moving Average 34.1392

Share Statistics

Avg Vol (3 month) 3968.64k
Avg Vol (10 day) 34.3M
Shares Outstanding 54.5M
Implied Shares Outstanding 6N/A
Float 4.37M
% Held by Insiders 12.93%
% Held by Institutions 126.47%
Shares Short (Apr 29, 2021) 4355.88k
Short Ratio (Apr 29, 2021) 42.51
Short % of Float (Apr 29, 2021) 47.94%
Short % of Shares Outstanding (Apr 29, 2021) 47.90%
Shares Short (prior month Mar 30, 2021) 4606k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 29, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Oct 29, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-40.99%
Return on Equity (ttm)-108.39%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -12.63M
Net Income Avi to Common (ttm)-14.13M
Diluted EPS (ttm)-4.0820
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.67M
Total Cash Per Share (mrq)3.26
Total Debt (mrq)934k
Total Debt/Equity (mrq)6.43
Current Ratio (mrq)2.81
Book Value Per Share (mrq)3.36

Cash Flow Statement

Operating Cash Flow (ttm)-11.51M
Levered Free Cash Flow (ttm)-5.99M